Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table.

Ranjbar, Mitra; Rahimi, Ali; Baghernejadan, Zeinab; Ghorbani, Atousa; Khorramdelazad, Hossein

Ranjbar, Mitra; Rahimi, Ali; Baghernejadan, Zeinab; Ghorbani, Atousa; Khorramdelazad, Hossein.

Afiliación

Ranjbar M; Department of Infectious Disease, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Rahimi A; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Baghernejadan Z; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ghorbani A; Department of Biology, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Khorramdelazad H; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Electronic address: Khorramdelazad@gmail.com.

Int Immunopharmacol ; 113(Pt A): 109325, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36252475

Asunto(s)

Tratamiento Farmacológico de COVID-19; Quimiocina CCL2; Humanos; SARS-CoV-2; Síndrome de Liberación de Citoquinas; Monocitos; Receptores CCR2

Palabras clave

CCL2; CCR2; COVID-19; CXCL17; Immunotherapy; MDSCs

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quimiocina CCL2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google